A1210477 sensitised 2 out of the 4 samples to ABT-737 (patient 20 and 26), confirming that repression of Mcl-1 is a key mechanism through which PHA-767491 sensitises AML cells under BMSC support to ABT-737. Here, MCL1 is linked to acute myeloid leukemia.